{"id":"W4389244115","doi":"10.1182/blood-2023-189358","title":"Gimema Seifem Real-Life Study VS Randomized CPX-351 Registrative Trial for Older Patients with Secondary ACUTE Myeloid Leukemia: An Unanchored Matching-Adjusted Indirect Comparison of Infection Rates and Survival Outcomes","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Daunorubicin; Regimen; Myeloid leukemia; Chemotherapy regimen; Randomized controlled trial; Clinical trial; Leukemia; Pediatrics; Oncology; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008126896,0.00106264,0.001825392,0.0004781329,0.0002141994,0.0008809748,0.0007476154,0.001106024,0.00315518],"category_scores_gemma":[0.01060981,0.0003366861,0.004615819,0.0004310756,0.0005778848,0.0007068716,0.000847095,0.002185924,0.0002255122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007842212,"about_ca_system_score_gemma":0.0006861996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007207947,"about_ca_topic_score_gemma":0.001193102,"domain_scores_codex":[0.9916276,0.007018614,0.0003378645,0.0004743781,0.0003089813,0.0002325887],"domain_scores_gemma":[0.9956205,0.001976959,0.001463586,0.0004978068,0.0001471224,0.0002940062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.921959,0.001724764,0.01243871,0.002226535,0.03305644,0.00006887763,0.0001434154,0.002035635,0.0009161124,0.001311027,0.001272663,0.02284688],"study_design_scores_gemma":[0.7821294,0.1006434,0.05703774,0.0007831171,0.03998274,0.0001898905,0.0001675135,0.007291188,0.001380241,0.003108056,0.007194375,0.00009218424],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787375,0.008735232,0.00246366,0.00109018,0.000510299,0.002749681,0.002758003,0.00006975807,0.002885672],"genre_scores_gemma":[0.9910709,0.0007080486,0.002276295,0.0006990834,0.0001930468,0.002613494,0.001524287,0.000008025326,0.0009068277],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008126896,"threshold_uncertainty_score":0.04297966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03444640972525172,"score_gpt":0.3457785500579785,"score_spread":0.3113321403327268,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}